...
机译:LNCRNA SNHG1通过靶向MIR-129-3P来调节肾细胞癌的免疫逸出,以激活Stat3和PD-L1
Zhengzhou Univ Affiliated Hosp 1 Dept Urol 1 Jianshe East Rd Zhengzhou 450052 Henan Peoples R;
Zhengzhou Univ Affiliated Hosp 1 Dept Urol 1 Jianshe East Rd Zhengzhou 450052 Henan Peoples R;
Zhengzhou Univ Affiliated Hosp 1 Dept Urol 1 Jianshe East Rd Zhengzhou 450052 Henan Peoples R;
Zhengzhou Univ Affiliated Hosp 1 Dept Urol 1 Jianshe East Rd Zhengzhou 450052 Henan Peoples R;
Zhengzhou Univ Affiliated Hosp 1 Dept Urol 1 Jianshe East Rd Zhengzhou 450052 Henan Peoples R;
immune escape; miRamp; 8208; 129amp; 8208; 3p; PDamp; 8208; L1; RCC; SNHG1; STAT3;
机译:LNCRNA SnHG1调节Treg细胞的分化,通过调节miR-448 / IDO影响乳腺癌的免疫逃逸
机译:LncRNA SNHG1通过激活Akt途径促进索拉非尼耐药,并在肝癌细胞中受到miR-21的正调控
机译:肝癌细胞内在TLR9激活通过PD-L1上调在肝细胞癌中诱导免疫逸出
机译:挽救口腔鳞状细胞癌免疫逃逸的新方法:干扰素-y和LY294002的联合使用
机译:PD-L1特异性辅助性T细胞表现出有效的抗肿瘤反应:针对头颈部鳞状细胞癌中PD-L1的癌症免疫疗法的新策略。
机译:LNCRNA SOX2-OT / MIR-30D-5P / PDK1通过MTOR信号通路调节PD-L1检查点以促进非小细胞肺癌进展和免疫逃逸
机译:LNCRNA SNHG1通过激活AKT途径有助于索拉芬蛋白电阻,并通过肝细胞癌细胞中的miR-21积极调节
机译:新型肿瘤抗原和Foxp3双靶向肿瘤细胞疫苗增强了小鼠肾细胞癌模型的免疫治疗。